世界の新型コロナウイルス感染症治療市場規模・現状・予測2021-2027

【英語タイトル】Global Covid-19 Therapeutic Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1631)・商品コード:QY21APR1631
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:126
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:New Technology
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、新型コロナウイルス感染症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(免疫療法、生命維持、抗ウイルス薬、血漿交換、その他)、用途別市場規模(子供、成人)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・新型コロナウイルス感染症治療の市場動向
・企業の競争状況、市場シェア
・新型コロナウイルス感染症治療の種類別市場規模(免疫療法、生命維持、抗ウイルス薬、血漿交換、その他)
・新型コロナウイルス感染症治療の用途別市場規模(子供、成人)
・新型コロナウイルス感染症治療の北米市場規模2016-2027(アメリカ、カナダ)
・新型コロナウイルス感染症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・新型コロナウイルス感染症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・新型コロナウイルス感染症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・新型コロナウイルス感染症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Cadila Healthcare、Johnson & Johnson、ImmunoPrecise、Novartis、AstraZeneca、Cipla、AbbVie、Bayer、Regeneron Pharmaceuticals、Ascletis Pharma、GlaxoSmithKline、Gilead Sciences、Pharmstandard、Fujifilm Holdings、Zhejiang Hisun Pharmaceutical Co. Ltd、Roche、Sanofi、Pfizer)
・結論
【レポートの概要】

In 2021, the global Covid-19 Therapeutic market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Covid-19 Therapeutic status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Covid-19 Therapeutic development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Covid-19 Therapeutic Scope and Market Size
Covid-19 Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Covid-19 Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunotherapy
Life Support
Antiviral Medicine
Plasma Therapy
Others

Segment by Application
Children
Adult

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type (2021-2027)
1.2.2 Immunotherapy
1.2.3 Life Support
1.2.4 Antiviral Medicine
1.2.5 Plasma Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Therapeutic Market Share by Application (2021-2027)
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Covid-19 Therapeutic Market Size
2.2 Covid-19 Therapeutic Market Size by Regions
2.2.1 Covid-19 Therapeutic Growth Rate by Regions (2021-2027)
2.2.2 Covid-19 Therapeutic Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Covid-19 Therapeutic Revenue by Players (2020-2021)
3.2 Covid-19 Therapeutic Key Players Headquaters and Area Served
3.3 Key Players Covid-19 Therapeutic Product/Solution/Service
3.4 Date of Enter into Covid-19 Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Covid-19 Therapeutic Market Size by Type (2021-2027)
4.2 Global Covid-19 Therapeutic Market Size by Application (2021-2027)

5 North America
5.1 North America Covid-19 Therapeutic Market Forecast (2021-2027)
5.2 Covid-19 Therapeutic Key Players in North America
5.3 North America Covid-19 Therapeutic Market Size by Type
5.4 North America Covid-19 Therapeutic Market Size by Application

6 Europe
6.1 Europe Covid-19 Therapeutic Market Forecast (2021-2027)
6.2 Covid-19 Therapeutic Key Players in Europe
6.3 Europe Covid-19 Therapeutic Market Size by Type
6.4 Europe Covid-19 Therapeutic Market Size by Application

7 Japan
7.1 Japan Covid-19 Therapeutic Market Forecast (2021-2027)
7.2 Covid-19 Therapeutic Key Players in Europe
7.3 Japan Covid-19 Therapeutic Market Size by Type
7.4 Japan Covid-19 Therapeutic Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Covid-19 Therapeutic Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Covid-19 Therapeutic Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Covid-19 Therapeutic Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 Cadila Healthcare
9.1.1 Cadila Healthcare Company Details
9.1.2 Cadila Healthcare Description and Business Overview
9.1.3 Cadila Healthcare Covid-19 Therapeutic Introduction
9.1.4 Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2020-2021)
9.1.5 Cadila Healthcare Recent Development
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Company Details
9.2.2 Johnson & Johnson Description and Business Overview
9.2.3 Johnson & Johnson Covid-19 Therapeutic Introduction
9.2.4 Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2020-2021)
9.2.5 Johnson & Johnson Recent Development
9.3 ImmunoPrecise
9.3.1 ImmunoPrecise Company Details
9.3.2 ImmunoPrecise Description and Business Overview
9.3.3 ImmunoPrecise Covid-19 Therapeutic Introduction
9.3.4 ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2020-2021)
9.3.5 ImmunoPrecise Recent Development
9.4 Novartis
9.4.1 Novartis Company Details
9.4.2 Novartis Description and Business Overview
9.4.3 Novartis Covid-19 Therapeutic Introduction
9.4.4 Novartis Revenue in Covid-19 Therapeutic Business (2020-2021)
9.4.5 Novartis Recent Development
9.5 AstraZeneca
9.5.1 AstraZeneca Company Details
9.5.2 AstraZeneca Description and Business Overview
9.5.3 AstraZeneca Covid-19 Therapeutic Introduction
9.5.4 AstraZeneca Revenue in Covid-19 Therapeutic Business (2020-2021)
9.5.5 AstraZeneca Recent Development
9.6 Cipla
9.6.1 Cipla Company Details
9.6.2 Cipla Description and Business Overview
9.6.3 Cipla Covid-19 Therapeutic Introduction
9.6.4 Cipla Revenue in Covid-19 Therapeutic Business (2020-2021)
9.6.5 Cipla Recent Development
9.7 AbbVie
9.7.1 AbbVie Company Details
9.7.2 AbbVie Description and Business Overview
9.7.3 AbbVie Covid-19 Therapeutic Introduction
9.7.4 AbbVie Revenue in Covid-19 Therapeutic Business (2020-2021)
9.7.5 AbbVie Recent Development
9.8 Bayer
9.8.1 Bayer Company Details
9.8.2 Bayer Description and Business Overview
9.8.3 Bayer Covid-19 Therapeutic Introduction
9.8.4 Bayer Revenue in Covid-19 Therapeutic Business (2020-2021)
9.8.5 Bayer Recent Development
9.9 Regeneron Pharmaceuticals
9.9.1 Regeneron Pharmaceuticals Company Details
9.9.2 Regeneron Pharmaceuticals Description and Business Overview
9.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Introduction
9.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2020-2021)
9.9.5 Regeneron Pharmaceuticals Recent Development
9.10 Ascletis Pharma
9.10.1 Ascletis Pharma Company Details
9.10.2 Ascletis Pharma Description and Business Overview
9.10.3 Ascletis Pharma Covid-19 Therapeutic Introduction
9.10.4 Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2020-2021)
9.10.5 Ascletis Pharma Recent Development
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Company Details
9.11.2 GlaxoSmithKline Description and Business Overview
9.11.3 GlaxoSmithKline Covid-19 Therapeutic Introduction
9.11.4 GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2020-2021)
9.11.5 GlaxoSmithKline Recent Development
9.12 Gilead Sciences
9.12.1 Gilead Sciences Company Details
9.12.2 Gilead Sciences Description and Business Overview
9.12.3 Gilead Sciences Covid-19 Therapeutic Introduction
9.12.4 Gilead Sciences Revenue in Covid-19 Therapeutic Business (2020-2021)
9.12.5 Gilead Sciences Recent Development
9.13 Pharmstandard
9.13.1 Pharmstandard Company Details
9.13.2 Pharmstandard Description and Business Overview
9.13.3 Pharmstandard Covid-19 Therapeutic Introduction
9.13.4 Pharmstandard Revenue in Covid-19 Therapeutic Business (2020-2021)
9.13.5 Pharmstandard Recent Development
9.14 Fujifilm Holdings
9.14.1 Fujifilm Holdings Company Details
9.14.2 Fujifilm Holdings Description and Business Overview
9.14.3 Fujifilm Holdings Covid-19 Therapeutic Introduction
9.14.4 Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2020-2021)
9.14.5 Fujifilm Holdings Recent Development
9.15 Zhejiang Hisun Pharmaceutical Co. Ltd
9.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
9.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
9.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Introduction
9.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2020-2021)
9.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
9.16 Roche
9.16.1 Company Details
9.16.2 Roche Description and Business Overview
9.16.3 Roche Covid-19 Therapeutic Introduction
9.16.4 Roche Revenue in Covid-19 Therapeutic Business (2020-2021)
9.16.5 Roche Recent Development
9.17 Sanofi
9.17.1 Sanofi Company Details
9.17.2 Sanofi Description and Business Overview
9.17.3 Sanofi Covid-19 Therapeutic Introduction
9.17.4 Sanofi Revenue in Covid-19 Therapeutic Business (2020-2021)
9.17.5 Sanofi Recent Development
9.18 Pfizer
9.18.1 Pfizer Company Details
9.18.2 Pfizer Description and Business Overview
9.18.3 Pfizer Covid-19 Therapeutic Introduction
9.18.4 Pfizer Revenue in Covid-19 Therapeutic Business (2020-2021)
9.18.5 Pfizer Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Covid-19 Therapeutic Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Life Support
Table 4. Key Players of Antiviral Medicine
Table 5. Key Players of Plasma Therapy
Table 6. Key Players of Others
Table 7. Global Covid-19 Therapeutic Market Size Growth by Application (2021-2027) (US$ Million)
Table 8. Global Covid-19 Therapeutic Market Size by Regions (2021-2027) (US$ Million)
Table 9. Global Covid-19 Therapeutic Market Share by Regions (2021-2027)
Table 10. Market Top Trends
Table 11. Market Use Cases
Table 12. Global Covid-19 Therapeutic Revenue by Players (2020-2021) (US$ Million)
Table 13. Global Covid-19 Therapeutic Market Share by Players (2020-2021)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Covid-19 Therapeutic Product Solution and Service
Table 16. Date of Enter into Covid-19 Therapeutic Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
Table 19. Global Covid-19 Therapeutic Market Size Share by Type (2021-2027)
Table 20. Global Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
Table 21. Global Covid-19 Therapeutic Market Size Share by Application (2021-2027)
Table 22. North America Key Players Covid-19 Therapeutic Revenue (2020-2021) (US$ Million)
Table 23. North America Key Players Covid-19 Therapeutic Market Share (2020-2021)
Table 24. North America Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
Table 25. North America Covid-19 Therapeutic Market Share by Type (2021-2027)
Table 26. North America Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
Table 27. North America Covid-19 Therapeutic Market Share by Application (2021-2027)
Table 28. Europe Key Players Covid-19 Therapeutic Revenue (2020-2021) (US$ Million)
Table 29. Europe Key Players Covid-19 Therapeutic Market Share (2020-2021)
Table 30. Europe Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
Table 31. Europe Covid-19 Therapeutic Market Share by Type (2021-2027)
Table 32. Europe Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
Table 33. Europe Covid-19 Therapeutic Market Share by Application (2021-2027)
Table 34. Japan Key Players Covid-19 Therapeutic Revenue (2020-2021) (US$ Million)
Table 35. Japan Key Players Covid-19 Therapeutic Market Share (2020-2021)
Table 36. Japan Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
Table 37. Japan Covid-19 Therapeutic Market Share by Type (2021-2027)
Table 38. Japan Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
Table 39. Japan Covid-19 Therapeutic Market Share by Application (2021-2027)
Table 40. Key Players in China
Table 41. Key Players in Southeast Asia
Table 42. Key Players in India
Table 43. Cadila Healthcare Company Details
Table 44. Cadila Healthcare Description and Business Overview
Table 45. Cadila Healthcare Covid-19 Therapeutic Product
Table 46. Cadila Healthcare Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 47. Cadila Healthcare Recent Development
Table 48. Johnson & Johnson Company Details
Table 49. Johnson & Johnson Description and Business Overview
Table 50. Johnson & Johnson Covid-19 Therapeutic Product
Table 51. Johnson & Johnson Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 52. Johnson & Johnson Recent Development
Table 53. ImmunoPrecise Company Details
Table 54. ImmunoPrecise Description and Business Overview
Table 55. ImmunoPrecise Covid-19 Therapeutic Product
Table 56. ImmunoPrecise Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 57. ImmunoPrecise Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Description and Business Overview
Table 60. Novartis Covid-19 Therapeutic Product
Table 61. Novartis Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 62. Novartis Recent Development
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Description and Business Overview
Table 65. AstraZeneca Covid-19 Therapeutic Product
Table 66. AstraZeneca Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 67. AstraZeneca Recent Development
Table 68. Cipla Company Details
Table 69. Cipla Description and Business Overview
Table 70. Cipla Covid-19 Therapeutic Product
Table 71. Cipla Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 72. Cipla Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Description and Business Overview
Table 75. AbbVie Covid-19 Therapeutic Product
Table 76. AbbVie Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 77. AbbVie Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Description and Business Overview
Table 80. Bayer Covid-19 Therapeutic Product
Table 81. Bayer Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 82. Bayer Recent Development
Table 83. Regeneron Pharmaceuticals Company Details
Table 84. Regeneron Pharmaceuticals Description and Business Overview
Table 85. Regeneron Pharmaceuticals Covid-19 Therapeutic Product
Table 86. Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 87. Regeneron Pharmaceuticals Recent Development
Table 88. Ascletis Pharma Company Details
Table 89. Ascletis Pharma Description and Business Overview
Table 90. Ascletis Pharma Covid-19 Therapeutic Product
Table 91. Ascletis Pharma Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 92. Ascletis Pharma Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Description and Business Overview
Table 95. GlaxoSmithKline Covid-19 Therapeutic Product
Table 96. GlaxoSmithKline Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 97. GlaxoSmithKline Recent Development
Table 98. Gilead Sciences Company Details
Table 99. Gilead Sciences Description and Business Overview
Table 100. Gilead Sciences Covid-19 Therapeutic Product
Table 101. Gilead Sciences Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 102. Gilead Sciences Recent Development
Table 103. Pharmstandard Company Details
Table 104. Pharmstandard Description and Business Overview
Table 105. Pharmstandard Covid-19 Therapeutic Product
Table 106. Pharmstandard Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 107. Pharmstandard Recent Development
Table 108. Fujifilm Holdings Company Details
Table 109. Fujifilm Holdings Description and Business Overview
Table 110. Fujifilm Holdings Covid-19 Therapeutic Product
Table 111. Fujifilm Holdings Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 112. Fujifilm Holdings Recent Development
Table 113. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
Table 114. Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
Table 115. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product
Table 116. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 117. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
Table 118. Roche Company Details
Table 119. Roche Description and Business Overview
Table 120. Roche Covid-19 Therapeutic Product
Table 121. Roche Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 122. Roche Recent Development
Table 123. Sanofi Company Details
Table 124. Sanofi Description and Business Overview
Table 125. Sanofi Covid-19 Therapeutic Product
Table 126. Sanofi Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 127. Sanofi Recent Development
Table 128. Pfizer Company Details
Table 129. Pfizer Description and Business Overview
Table 130. Pfizer Covid-19 Therapeutic Product
Table 131. Pfizer Revenue in Covid-19 Therapeutic Business 2020 and 2021
Table 132. Pfizer Recent Development
Table 133. Covid-19 Therapeutic Market Trends
Table 134. Covid-19 Therapeutic Market Drivers
Table 135. Covid-19 Therapeutic Market Challenges
Table 136. Covid-19 Therapeutic Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Therapeutic Market Share by Type in 2021 & 2027
Figure 2. Immunotherapy Features
Figure 3. Life Support Features
Figure 4. Antiviral Medicine Features
Figure 5. Plasma Therapy Features
Figure 6. Others Features
Figure 7. Global Covid-19 Therapeutic Market Share by Application in 2021 & 2027
Figure 8. Children Case Studies
Figure 9. Adult Case Studies
Figure 10. Covid-19 Therapeutic Report Years Considered
Figure 11. Global Covid-19 Therapeutic Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 12. Global Covid-19 Therapeutic Market Share by Regions (2020-2027)
Figure 13. Global Covid-19 Therapeutic Market Share by Players in 2021
Figure 14. Global Covid-19 Therapeutic Market Size Market Share by Type (2021-2027)
Figure 15. Global Covid-19 Therapeutic Market Size Market Share by Application (2021-2027)
Figure 16. Global Covid-19 Therapeutic Revenue Market Share by Application in 2021
Figure 17. North America Covid-19 Therapeutic Market Size 2021-2027 (US$ Million)
Figure 18. Europe Covid-19 Therapeutic Market Size 2021-2027 (US$ Million)
Figure 19. Japan Covid-19 Therapeutic Market Size 2021-2027 (US$ Million)
Figure 20. Covid-19 Therapeutic Market Size in China (2021-2027) (US$ Million)
Figure 21. Covid-19 Therapeutic Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 22. Covid-19 Therapeutic Market Size in India (2021-2027) (US$ Million)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed


【掲載企業】

Cadila Healthcare、Johnson & Johnson、ImmunoPrecise、Novartis、AstraZeneca、Cipla、AbbVie、Bayer、Regeneron Pharmaceuticals、Ascletis Pharma、GlaxoSmithKline、Gilead Sciences、Pharmstandard、Fujifilm Holdings、Zhejiang Hisun Pharmaceutical Co. Ltd、Roche、Sanofi、Pfizer

★調査レポート[世界の新型コロナウイルス感染症治療市場規模・現状・予測2021-2027] (コード:QY21APR1631)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の新型コロナウイルス感染症治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆